Urologist Key to Patient Grasp of Tobacco-Bladder Cancer Link

This article originally appeared here.
Share this content:
Urologist Key to Patient Grasp of Tobacco-Bladder Cancer Link
Urologist Key to Patient Grasp of Tobacco-Bladder Cancer Link

(HealthDay News) -- For patients with bladder cancer, smoking status and primary source of information correlate with awareness of the harms of tobacco use, according to a study published online Nov. 10 in Cancer.

Jeffrey C. Basset, M.D., M.P.H., from the University of California in Los Angeles, and colleagues surveyed a stratified, random sample of bladder cancer survivors about tobacco use, risk factors, and sources of information on the causes of bladder cancer. Seven hundred ninety eligible participants completed the survey.

Of the cohort, 68 percent had a history of tobacco use and 19 percent were active smokers at baseline. The researchers found that the most cited risk factor for bladder cancer was tobacco use, with active smokers more knowledgeable than former or never smokers (90 versus 64 and 61 percent, respectively; P < 0.001). The predominant source of information was urologists, with active smokers most often citing them (82 percent). Compared with never smokers, active smokers had 6.37-fold higher odds of endorsing tobacco use as a risk factor for bladder cancer, in multivariate analyses. Smokers who cited their urologist as their information source had 2.80-fold higher odds of believing their cancer was caused by tobacco use.

"Urologists play a critical role in ensuring patients' knowledge of the connection between smoking and bladder cancer, particularly for active smokers who may be motivated to quit," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »